Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

6 structures for Q9Y3E1

Entry ID Method Resolution Chain Position Source
6IIP X-ray 095 A A/B 8-94 PDB
6IIQ X-ray 185 A A/B/C 1-99 PDB
6IIR X-ray 220 A A/B 1-99 PDB
6IIS X-ray 236 A A/B 1-99 PDB
6IIT X-ray 210 A A/B 1-99 PDB
AF-Q9Y3E1-F1 Predicted AlphaFoldDB

117 variants for Q9Y3E1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1453088922
CA393314427
2 A>S No ClinGen
gnomAD
CA393314424
rs1395510807
2 A>V No ClinGen
gnomAD
CA393314418
rs1463740501
3 R>L No ClinGen
gnomAD
CA393314401
rs1373679790
6 P>L No ClinGen
gnomAD
CA7703682
rs751477122
7 R>C No ClinGen
ExAC
gnomAD
rs764106646
CA7703681
7 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA393314389
rs1469972532
8 E>D No ClinGen
TOPMed
gnomAD
rs1231600119
CA393314388
9 Y>N No ClinGen
gnomAD
rs1203349272
CA393314367
11 A>V No ClinGen
TOPMed
rs1483427154
CA393314356
13 D>G No ClinGen
TOPMed
CA393314313
rs1248880614
19 M>I No ClinGen
gnomAD
rs910220280
CA273506615
21 G>C No ClinGen
TOPMed
rs1418612575
CA393314280
24 H>P No ClinGen
TOPMed
rs1416727025
CA393320809
34 E>A No ClinGen
gnomAD
CA393320754
rs1179267703
42 N>K No ClinGen
TOPMed
rs1449599571
CA393320740
44 Y>C No ClinGen
gnomAD
rs1172332473
CA393320729
46 I>V No ClinGen
gnomAD
rs1567170453 49 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA393320688
rs1384525474
51 T>I No ClinGen
gnomAD
rs559173257
CA7703641
54 T>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA7703619
rs779885695
57 L>I No ClinGen
ExAC
gnomAD
TCGA novel 59 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1284242851
CA393319680
60 K>E No ClinGen
gnomAD
CA7703618
rs757419110
64 P>T No ClinGen
ExAC
gnomAD
CA393319611
rs1375984187
65 Y>C No ClinGen
TOPMed
gnomAD
rs1375984187
CA393319609
65 Y>F No ClinGen
TOPMed
gnomAD
TCGA novel 70 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA393319544
rs1344276226
72 F>L No ClinGen
gnomAD
CA393319537
rs1300709314
73 G>R No ClinGen
gnomAD
rs758456840
CA7703615
78 R>Q No ClinGen
ExAC
gnomAD
rs1426059260
CA393319500
78 R>W No ClinGen
TOPMed
gnomAD
CA393319469
rs145113533
82 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs373778313
CA7703613
83 E>K No ClinGen
ESP
ExAC
gnomAD
rs1267088572
CA393319422
89 E>Q No ClinGen
gnomAD
rs1201662800
CA393319414
90 N>D No ClinGen
gnomAD
CA273512671
rs917961875
90 N>S No ClinGen
Ensembl
rs1201662800
CA393319413
90 N>Y No ClinGen
gnomAD
CA7703610
rs766698301
92 P>A No ClinGen
ExAC
gnomAD
TCGA novel 95 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA273512647
rs992291510
96 F>L No ClinGen
TOPMed
gnomAD
rs772870099
CA7703608
97 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs747659212
CA393319352
99 Y>* No ClinGen
ExAC
gnomAD
rs201298885
CA273512646
99 Y>C No ClinGen
Ensembl
rs11546524
CA273512238
101 A>G No ClinGen
Ensembl
CA393319092
rs11546524
101 A>V No ClinGen
Ensembl
rs200230620
CA7703584
102 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1029857853
CA273512231
103 Q>R No ClinGen
TOPMed
CA7703583
rs554837315
104 Q>K No ClinGen
1000Genomes
ExAC
gnomAD
CA7703582
rs762467126
105 Q>E No ClinGen
ExAC
gnomAD
CA7703581
rs775359190
105 Q>R No ClinGen
ExAC
gnomAD
CA273512189
rs994754800
106 S>R No ClinGen
Ensembl
CA393319014
rs1304753878
107 S>C No ClinGen
gnomAD
TCGA novel 107 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1170470520
CA393318878
114 G>S No ClinGen
gnomAD
CA393318866
rs1408893011
115 G>R No ClinGen
gnomAD
rs199682422
CA273512186
117 T>I No ClinGen
Ensembl
CA393318763
rs1168390472
120 A>V No ClinGen
gnomAD
CA7703579
rs769653213
121 S>G No ClinGen
ExAC
gnomAD
CA273512177
rs961091056
123 E>D No ClinGen
TOPMed
gnomAD
rs1464807803
CA393318686
124 E>G No ClinGen
TOPMed
CA273512169
rs542804499
126 G>D No ClinGen
gnomAD
CA7703578
rs745645445
127 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1016644390
CA273512168
129 V>I No ClinGen
gnomAD
CA393318563
rs1446796969
130 E>A No ClinGen
TOPMed
TCGA novel 130 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA393318568
rs1201779251
130 E>Q No ClinGen
gnomAD
rs1567168933
CA393318527
131 E>D No ClinGen
Ensembl
rs1483356064
CA393318517
132 D>V No ClinGen
gnomAD
rs1005142659
CA273512140
133 G>A No ClinGen
TOPMed
gnomAD
TCGA novel 133 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel
CA393318498
rs1331098792
133 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
TOPMed
NCI-TCGA
CA273512130
rs147777221
134 K>Q No ClinGen
ESP
TOPMed
rs780899046
CA7703576
135 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA393318403
rs1298167820
138 K>R No ClinGen
gnomAD
CA7703575
rs535249266
139 N>I No ClinGen
1000Genomes
ExAC
gnomAD
CA393318378
rs1380249447
140 E>K No ClinGen
gnomAD
rs1314567198
CA393318366
140 E>V No ClinGen
gnomAD
rs1396436479
CA393318312
143 G>V No ClinGen
TOPMed
gnomAD
CA7703574
rs748314372
146 R>L No ClinGen
ExAC
gnomAD
COSM1719039
CA273512096
rs748314372
146 R>Q NS [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA273512073
rs370356351
150 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1431630854
CA393318208
150 Y>H No ClinGen
gnomAD
rs370356351
CA7703573
150 Y>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA393318172
rs1185596503
152 S>L No ClinGen
gnomAD
rs1163452027
CA393318167
153 K>E No ClinGen
gnomAD
rs1225283916
CA393316857
158 Q>E No ClinGen
TOPMed
rs1284607933
CA393316823
159 S>P No ClinGen
TOPMed
COSM297235
rs781730104
CA7703547
160 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs781098686
CA273507669
160 R>W No ClinGen
gnomAD
rs1383484540
CA393316778
161 K>Q No ClinGen
gnomAD
rs1161793568
CA393316753
162 S>T No ClinGen
gnomAD
CA273507665
rs868583090
164 G>V No ClinGen
Ensembl
rs757571791
CA7703546
165 D>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 169 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1567167475
CA393316576
170 D>H No ClinGen
Ensembl
CA393316548
rs1298106037
171 C>F No ClinGen
TOPMed
gnomAD
CA393316534
rs1476721760
172 K>R No ClinGen
gnomAD
CA393316488
rs1440756170
174 E>K No ClinGen
gnomAD
CA7703544
rs763707408
177 K>R No ClinGen
ExAC
gnomAD
rs917837315
CA273507619
179 S>R No ClinGen
TOPMed
rs990706628
CA273507608
183 G>E No ClinGen
TOPMed
COSM244873
rs1446324632
CA393316249
185 A>V prostate [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA7703542
rs188845179
186 G>D No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA393316218
rs188845179
186 G>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA393316205
rs1172051462
187 N>S No ClinGen
TOPMed
rs981197648
CA273507553
188 D>N No ClinGen
TOPMed
gnomAD
CA7703540
rs759098896
189 T>A No ClinGen
ExAC
gnomAD
CA393316151
rs1347160614
189 T>I No ClinGen
TOPMed
gnomAD
CA393316152
rs1347160614
189 T>R No ClinGen
TOPMed
gnomAD
CA393316136
rs1333908919
190 R>S No ClinGen
TOPMed
CA393316094
rs1275477672
193 T>A No ClinGen
gnomAD
rs1444228562
CA393316083
193 T>I No ClinGen
TOPMed
CA393316040
rs1226844496
196 L>M No ClinGen
gnomAD
rs776381808
CA7703539
200 S>G No ClinGen
ExAC
gnomAD
CA393315959
rs1567167441
200 S>N No ClinGen
Ensembl
CA393315914
rs1436275682
201 E>D No ClinGen
gnomAD
rs766448688
CA7703538
202 G>R No ClinGen
ExAC
gnomAD

No associated diseases with Q9Y3E1

2 regional properties for Q9Y3E1

Type Name Position InterPro Accession
domain PWWP domain 5 - 86 IPR000313
domain Lens epithelium-derived growth factor, integrase-binding domain 472 - 569 IPR021567

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

5 GO annotations of molecular function

Name Definition
double-stranded DNA binding Binding to double-stranded DNA.
growth factor activity The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
microtubule binding Binding to a microtubule, a filament composed of tubulin monomers.
transcription coregulator activity A transcription regulator activity that modulates the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Coregulators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators.
tubulin binding Binding to monomeric or multimeric forms of tubulin, including microtubules.

4 GO annotations of biological process

Name Definition
microtubule polymerization The addition of tubulin heterodimers to one or both ends of a microtubule.
negative regulation of microtubule depolymerization Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.
neuron projection development The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8MJG1 PSIP1 PC4 and SFRS1-interacting protein Bos taurus (Bovine) PR
Q9XSK7 HDGF Hepatoma-derived growth factor Bos taurus (Bovine) PR
Q66T72 PSIP1 PC4 and SFRS1-interacting protein Felis catus (Cat) (Felis silvestris catus) PR
Q5XXA9 PSIP1 Lens epithelium-derived growth factor Gallus gallus (Chicken) PR
P51858 HDGF Hepatoma-derived growth factor Homo sapiens (Human) PR
O75475 PSIP1 PC4 and SFRS1-interacting protein Homo sapiens (Human) PR
Q7Z4V5 HDGFL2 Hepatoma-derived growth factor-related protein 2 Homo sapiens (Human) PR
Q99JF8 Psip1 PC4 and SFRS1-interacting protein Mus musculus (Mouse) PR
P51859 Hdgf Hepatoma-derived growth factor Mus musculus (Mouse) PR
Q9JMG7 Hdgfl3 Hepatoma-derived growth factor-related protein 3 Mus musculus (Mouse) PR
Q812D1 Psip1 PC4 and SFRS1-interacting protein Rattus norvegicus (Rat) PR
Q8VHK7 Hdgf Hepatoma-derived growth factor Rattus norvegicus (Rat) PR
Q923W4 Hdgfl3 Hepatoma-derived growth factor-related protein 3 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MARPRPREYK AGDLVFAKMK GYPHWPARID ELPEGAVKPP ANKYPIFFFG THETAFLGPK
70 80 90 100 110 120
DLFPYKEYKD KFGKSNKRKG FNEGLWEIEN NPGVKFTGYQ AIQQQSSSET EGEGGNTADA
130 140 150 160 170 180
SSEEEGDRVE EDGKGKRKNE KAGSKRKKSY TSKKSSKQSR KSPGDEDDKD CKEEENKSSS
190 200
EGGDAGNDTR NTTSDLQKTS EGT